In UCS and ESS samples, we identified mutations in genes that demonstrated alterations in previous studies conducted for examining other tumors, such as PIK3CA, DICER1, AR, and NF (22). This evidence concerns the gene PIK3CA and endometrioid stromal sarcoma.